Insider Transactions

What Roivant Sciences Ltd.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	1
Sells	33	118
Total trades	57	243

Shares traded

	3 months	12 months
Acquired	2,629,473	26,669,919
Disposed	7,330,967	46,869,531
Net activity	−4,701,494	−20,199,612

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Venker Eric	President & Immunovant CEO	Aug 28	Disclosed 10b5-1 sale · S	−33,818	$36.44	−$1.23M	1,599,154
Venker Eric	President & Immunovant CEO	Aug 28	Disclosed 10b5-1 sale · S	−166,182	$35.63	−$5.92M	1,632,972
Venker Eric	President & Immunovant CEO	Aug 28	Exercise / conversion · M	+200,000	$3.85	+$770K	1,799,154
Sukhatme Mayukh	President & CIO	Aug 21	Open-market sale · S	−144,756	$36.48	−$5.28M	18,630,739
Sukhatme Mayukh	President & CIO	Aug 21	Exercise / conversion · M	+144,756	$3.85	+$557K	18,775,495
Venker Eric	President & Immunovant CEO	Aug 20	Withheld — tax / exercise cost · F	−13,909	$36.84	−$512K	1,599,154
Pulik Richard	CFO	Aug 20	Withheld — tax / exercise cost · F	−5,749	$36.84	−$212K	271,810
Sukhatme Mayukh	President & CIO	Aug 20	Open-market sale · S	−17,519	$37.30	−$653K	18,630,739
Sukhatme Mayukh	President & CIO	Aug 20	Exercise / conversion · M	+17,519	$3.85	+$67.4K	18,648,258
Sukhatme Mayukh	President & CIO	Aug 19	Open-market sale · S	−172,899	$37.17	−$6.43M	18,630,739
Sukhatme Mayukh	President & CIO	Aug 19	Exercise / conversion · M	+172,899	$3.85	+$666K	18,803,638
Sukhatme Mayukh	President & CIO	Aug 18	Open-market sale · S	−31,801	$37.18	−$1.18M	18,630,739
Sukhatme Mayukh	President & CIO	Aug 18	Exercise / conversion · M	+31,801	$3.85	+$122K	18,662,540
Sukhatme Mayukh	President & CIO	Aug 18	Open-market sale · S	−105,141	$36.59	−$3.85M	18,630,739
Sukhatme Mayukh	President & CIO	Aug 18	Exercise / conversion · M	+105,141	$3.85	+$405K	18,735,880
Sukhatme Mayukh	President & CIO	Aug 17	Open-market sale · S	−284,707	$36.25	−$10.3M	18,630,739
Sukhatme Mayukh	President & CIO	Aug 17	Exercise / conversion · M	+284,707	$3.85	+$1.1M	18,915,446
Sukhatme Mayukh	President & CIO	Aug 14	Open-market sale · S	−243,177	$36.23	−$8.81M	18,630,739
Sukhatme Mayukh	President & CIO	Aug 14	Exercise / conversion · M	+243,177	$3.85	+$936K	18,873,916
Venker Eric	President & Immunovant CEO	Jul 27	Open-market sale · S	−200,000	$34.95	−$6.99M	1,613,063

Page 1 of 39 · showing the 20 most recent Sign up free to view all 780 transactions and filter by insider →